Clarithromycin

Active ingredient description

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Clarithromycin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Medicines

Clarithromycin is the active ingredient of these drugs:

Drug
Countries

Hong Kong

Poland

Hong Kong

Canada

Singapore

Hong Kong

Brazil

South Africa

Hong Kong

Italy

Tunisia

Australia Hong Kong

Cyprus Hong Kong

South Africa

Singapore

Hong Kong

South Africa

Tunisia

South Africa

Hong Kong Singapore

South Africa

Brazil

Germany

Tunisia

Singapore

Cyprus Singapore

Italy

Hong Kong Singapore

Hong Kong

Finland

Singapore

Italy

Tunisia

Singapore

Singapore

Cyprus Hong Kong Singapore

Ireland

Ireland

Singapore

Tunisia

Estonia Lithuania Poland

Singapore

Australia

Hong Kong

Estonia Lithuania Poland

Poland

Poland

Australia Austria Estonia Finland Germany

New Zealand

South Africa

Hong Kong Singapore

Ireland

Tunisia

South Africa

Brazil United Kingdom

Ireland

South Africa

South Africa

South Africa

Poland

Tunisia

South Africa

South Africa

Estonia

Cyprus Estonia Hong Kong Lithuania Singapore

South Africa

Italy

Italy

Estonia Lithuania Poland

Italy

Hong Kong Lithuania

Hong Kong

Singapore

Cyprus

Hong Kong

Italy

Hong Kong

Poland

Italy

Italy

United Kingdom

Tunisia

Finland France Tunisia

Tunisia

Clarithromycin is also found within below combination drugs:

ESOGASTRO IBP , HELIPAK K , HP-PAC , NEXIUM HP7 , OMEPRAMIX , PANCLAMOX , PYLORIPAC

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
CY
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

H1250JIK0A - CLARITHROMYCIN

CAS registry number

81103-11-9 - clarithromycin

SNOMED-CT

387487009 - Clarithromycin (substance)